Doximity, Inc.(DOCS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DOCS Doximity, Inc.

Trading 12-12 10:24:12 EST

44.28

+0.15

+0.34%

High44.87	Low43.87	Vol352.72K
Open43.97	D1 Closing44.13	Amplitude2.25%
Mkt Cap8.34B	Tradable Cap5.89B	Total Shares188.27M
T/O15.69M	T/O Rate0.26%	Tradable Shares133.13M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DOCS","market":"US","secType":"STK","nameCN":"Doximity, Inc.","latestPrice":44.28,"timestamp":1765553051346,"preClose":44.13,"halted":0,"volume":352722,"delay":0,"floatShares":133129121,"shares":188271269,"eps":1.248726,"marketStatus":"Trading","change":0.15,"latestTime":"12-12 10:24:12 EST","open":43.965,"high":44.865,"low":43.87,"amount":15690778.207260001,"amplitude":0.022547,"askPrice":44.3,"askSize":29,"bidPrice":44.26,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.248726,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765573200000},"marketStatusCode":2,"adr":0,"listingDate":1624507200000,"exchange":"NYSE","adjPreClose":44.13,"preHourTrading":{"tag":"盘前","latestPrice":44.2,"preClose":44.13,"latestTime":"09:17 EST","volume":122,"amount":5393.46018,"timestamp":1765549029817},"postHourTrading":{"tag":"盘后","latestPrice":44.99,"preClose":44.13,"latestTime":"19:47 EST","volume":117303,"amount":5179315.0217,"timestamp":1765500458149},"volumeRatio":0.555139,"impliedVol":0.4129,"impliedVolPercentile":0.176},"requestUrl":"/m/hq/s/DOCS/tweets","defaultTab":"tweets","newsList":[{"id":"2590437340","title":"Doximity Initiated at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2590437340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590437340?lang=en_us&edition=fundamental","pubTime":"2025-12-09 23:50","pubTimestamp":1765295400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DOCS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2025 10:50 ET (15:50 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOCS"],"gpt_icon":0},{"id":"2590882318","title":"U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico","url":"https://stock-news.laohu8.com/highlight/detail?id=2590882318","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590882318?lang=en_us&edition=fundamental","pubTime":"2025-12-09 15:07","pubTimestamp":1765264045,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico Dec 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AstraZeneca,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nL4N3XF0GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DE","ANIP","CAH","AMRX","DH","AAPL","NVST","CIM","AR","ARWR","BTSG","CIEN","DAN","CFLT","GKOS","KR","COR","CCRN","CL","FMC","MACW.SI","DOCS","DYN","IE00BZ9MQY76.HKD","LU0997586432.USD","AZN.UK","DLTR","ADBE","AMPH","APD","AVGO","COLL","AAL","LU0154236417.USD","LU0964806797.USD","LU2552382058.USD","GLXY","BWA","ELAN","GM","CGEM","ALEX","DAL","03165","IE00BK4W5M84.HKD","IE00B775SV38.USD","AZN","ALGN","XRAY","CRC"],"gpt_icon":0},{"id":"2588021111","title":"Doximity Director Kira Scherer Wampler Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588021111","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588021111?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:03","pubTimestamp":1764795818,"startTime":"0","endTime":"0","summary":"Kira Scherer Wampler, Director at Doximity Inc., has reported a disposal of common shares of Doximity Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Doximity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL94vWgY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Doximity Director Kira Scherer Wampler Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4613","BK4539","DOCS","BK4551","BK4588","BK4167"],"gpt_icon":0},{"id":"2587873791","title":"Berenberg Bank Reaffirms Their Buy Rating on Dr. Martens Plc (DOCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2587873791","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587873791?lang=en_us&edition=fundamental","pubTime":"2025-11-29 04:56","pubTimestamp":1764363363,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Anne Critchlow from Berenberg Bank reiterated a Buy rating on Dr. Martens Plc, with a price target of p114.00. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/berenberg-bank-reaffirms-their-buy-rating-on-dr-martens-plc-docs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/berenberg-bank-reaffirms-their-buy-rating-on-dr-martens-plc-docs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DOCS"],"gpt_icon":0},{"id":"2586906694","title":"Doximity Director Timothy S. Cabral Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586906694","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586906694?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:07","pubTimestamp":1764018441,"startTime":"0","endTime":"0","summary":"Timothy S. Cabral, a director at Doximity Inc., has reported a disposal of common shares of Doximity Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Doximity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 24, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL4YM4Br:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Doximity Director Timothy S. Cabral Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","BK4585","DOCS","BK4551","BK4588","BK4613","BK4539"],"gpt_icon":0},{"id":"2585124012","title":"Dr. Martens Earnings Call: Mixed Sentiments and Strategic Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2585124012","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585124012?lang=en_us&edition=fundamental","pubTime":"2025-11-22 08:11","pubTimestamp":1763770318,"startTime":"0","endTime":"0","summary":"Dr. Martens Plc (($GB:DOCS)) has held its Q2 earnings call. Read on for the main highlights of the call. Dr. Martens Plc’s recent earnings call rev...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dr-martens-earnings-call-mixed-sentiments-and-strategic-moves?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dr-martens-earnings-call-mixed-sentiments-and-strategic-moves?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DOCS","BK4167","BK4539","BK4588","BK4551","BK4585","BK4613"],"gpt_icon":0},{"id":"2585128696","title":"BUZZ-U.S. STOCKS ON THE MOVE-IES Holding, Eli Lilly, Alphabet","url":"https://stock-news.laohu8.com/highlight/detail?id=2585128696","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585128696?lang=en_us&edition=fundamental","pubTime":"2025-11-22 02:44","pubTimestamp":1763750694,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-IES Holding, Eli Lilly, AlphabetEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nL6N3WX0O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBWI","GAP","DOCS","VFS","3NVD.UK","NVDY","TMUS","WDAY","NVIW.SI","2NVD.UK","NFE","AZTA","AHR","SNVD.UK","LOW","NVD2.UK","NVDS.UK","INTU","BJ","OGE","RIOT","PHM","DHI","LU0868494708.USD","NVDD","ESPR","NVD","GOOGL","NVD3.UK","IESC","LU1880398471.USD","NVRI","NVDU","CPRT","ANAB","LU0957808578.USD","NVDS"],"gpt_icon":1},{"id":"2585476140","title":"BUZZ-Doximity rises after Raymond James upgrades to 'strong buy'","url":"https://stock-news.laohu8.com/highlight/detail?id=2585476140","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585476140?lang=en_us&edition=fundamental","pubTime":"2025-11-22 02:07","pubTimestamp":1763748477,"startTime":"0","endTime":"0","summary":"BUZZ-Doximity rises after Raymond James upgrades to 'strong buy'** Shares of telehealth company Doximity <DOCS.N> up 8.8% at $50.47** Raymond James upgrades to \"strong buy\" from \"outperform\" rating; PT at $65** Brokerage sees potential from AI monetization and possible shifts toward direct-to-consumer for healthcare providers, which could support above-market growth** Sees long-term growth visibility and durability continues to improve ** 11 of 21 brokerages rate the stock \"buy\" or higher, 10 \"hold\"; their median PT is $65 - data compiled by LSEG ** As of last close, stock down ~13% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nL6N3WX10R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","DOCS","BK4167","BK4539","BK4551","BK4585","BK4588"],"gpt_icon":0},{"id":"2585480521","title":"Doximity Shares up 2.6% Premarket After Raymond James Raises to Strong Buy From Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2585480521","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585480521?lang=en_us&edition=fundamental","pubTime":"2025-11-21 20:53","pubTimestamp":1763729610,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nL4N3WX0X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4539","BK4613","DOCS","BK4167","BK4585","BK4551"],"gpt_icon":0},{"id":"2585113257","title":"Doximity Inc : Raymond James Raises to Strong Buy From Outperform; Cuts Target Price to $65 From $75","url":"https://stock-news.laohu8.com/highlight/detail?id=2585113257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585113257?lang=en_us&edition=fundamental","pubTime":"2025-11-21 16:53","pubTimestamp":1763715188,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nFWN3WX0F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4588","BK4167","BK4613","DOCS","BK4585","BK4551"],"gpt_icon":0},{"id":"2585511858","title":"Dr. Martens Plc (DOCS) Gets a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2585511858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585511858?lang=en_us&edition=fundamental","pubTime":"2025-11-21 16:06","pubTimestamp":1763712408,"startTime":"0","endTime":"0","summary":"In a report released today, Richard Taylor from Barclays maintained a Hold rating on Dr. Martens Plc, with a price target of £0.85. Taylor covers t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dr-martens-plc-docs-gets-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dr-martens-plc-docs-gets-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4588","BK4613","BK4167","DOCS","BK4585","BK4539"],"gpt_icon":0},{"id":"2585719437","title":"Goldman Sachs Sticks to Their Hold Rating for Dr. Martens Plc (DOCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2585719437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585719437?lang=en_us&edition=fundamental","pubTime":"2025-11-21 14:25","pubTimestamp":1763706327,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Adrien Duverger maintained a Hold rating on Dr. Martens Plc yesterday and set a price target of p83.00. The company’s shares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-sticks-to-their-hold-rating-for-dr-martens-plc-docs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-sticks-to-their-hold-rating-for-dr-martens-plc-docs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DOCS"],"gpt_icon":0},{"id":"2585315910","title":"Peel Hunt Reaffirms Their Buy Rating on Dr. Martens Plc (DOCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2585315910","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585315910?lang=en_us&edition=fundamental","pubTime":"2025-11-21 00:57","pubTimestamp":1763657875,"startTime":"0","endTime":"0","summary":"In a report released today, John Stevenson from Peel Hunt reiterated a Buy rating on Dr. Martens Plc, with a price target of p112.00. According to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/peel-hunt-reaffirms-their-buy-rating-on-dr-martens-plc-docs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/peel-hunt-reaffirms-their-buy-rating-on-dr-martens-plc-docs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DOCS"],"gpt_icon":0},{"id":"2584185965","title":"Can Doximity’s (DOCS) Share Buybacks and Earnings Strength Tell Us More About Its Growth Vision?","url":"https://stock-news.laohu8.com/highlight/detail?id=2584185965","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584185965?lang=en_us&edition=fundamental","pubTime":"2025-11-20 12:44","pubTimestamp":1763613896,"startTime":"0","endTime":"0","summary":"Doximity, Inc. recently reported its second quarter and six-month earnings for the period ended September 30, 2025, highlighting sales of US$168.53 million and net income of US$62.06 million for the quarter, both up from the same period last year, along with updated revenue guidance for the upcoming quarter and fiscal year.\nThe company also completed a tranche of its share repurchase program, which may indicate management's confidence in Doximity's long-term prospects.\nWe'll examine how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/can-doximitys-docs-share-buybacks-and-earnings-strength-tell","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/can-doximitys-docs-share-buybacks-and-earnings-strength-tell","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DOCS"],"gpt_icon":0},{"id":"2583934895","title":"Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive'","url":"https://stock-news.laohu8.com/highlight/detail?id=2583934895","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583934895?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:20","pubTimestamp":1763040000,"startTime":"0","endTime":"0","summary":"On CNBC's \"Mad Money Lightning Round,\" Jim Cramer recommended waiting and not buying Doximity, adding that it is \"still too expensive.\"","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/13/Jim-Cramer.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/13/Jim-Cramer.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/48831793/jim-cramer-dont-buy-this-health-care-stock-yet-it-is-still-too-expensive","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/48831793/jim-cramer-dont-buy-this-health-care-stock-yet-it-is-still-too-expensive","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4539","BK4551","BK4588","DOCS","BK4613","BK4516","BK4104","BK4585","BK4600","BK4595","BK4023","BK4167","BCC","BK4567"],"gpt_icon":1},{"id":"2582377564","title":"Dr. Martens Directors Participate in Share Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2582377564","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582377564?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:17","pubTimestamp":1762957077,"startTime":"0","endTime":"0","summary":"Dr. Martens Plc ( ($GB:DOCS) ) just unveiled an announcement. Dr. Martens Plc announced a transaction involving its Share Incentive Plan (SIP), whe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dr-martens-directors-participate-in-share-incentive-plan-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dr-martens-directors-participate-in-share-incentive-plan-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4613","BK4585","BK4588","DOCS","BK4539","BK4167"],"gpt_icon":0},{"id":"2582317885","title":"Dr. Martens Plc (DOCS) Receives a Hold from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2582317885","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582317885?lang=en_us&edition=fundamental","pubTime":"2025-11-12 09:48","pubTimestamp":1762912127,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Piral Dadhania maintained a Hold rating on Dr. Martens Plc yesterday and set a price target of p100.00. Dadhania covers the Con...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dr-martens-plc-docs-receives-a-hold-from-rbc-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dr-martens-plc-docs-receives-a-hold-from-rbc-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","LU0029864427.USD","LU0128525929.USD","BK4539","BK4585","LU0310800379.SGD","BK4588","BK4551","LU0708994859.HKD","BK4613","BK4167","LU1267930573.SGD","DOCS"],"gpt_icon":0},{"id":"2582364619","title":"Analysts Conflicted on These Healthcare Names: Madrigal Pharmaceuticals (MDGL), Doximity (DOCS) and Sutro Biopharma (STRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582364619","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582364619?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:30","pubTimestamp":1762867831,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Madrigal Pharmaceuticals (MDGL – Research Report), Doximity (DOCS...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-madrigal-pharmaceuticals-mdgl-doximity-docs-and-sutro-biopharma-stro-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-madrigal-pharmaceuticals-mdgl-doximity-docs-and-sutro-biopharma-stro-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4137","HCSG","LU0029874061.USD","LU0128526141.USD","BK4585","STRO","BK4581","MDGL","XBI","BK4588","XLV","BK4139","BK4551","BK4613","BK4167","DOCS","LABU"],"gpt_icon":0},{"id":"2582802755","title":"Doximity Is Maintained at Hold by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2582802755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582802755?lang=en_us&edition=fundamental","pubTime":"2025-11-11 04:39","pubTimestamp":1762807140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DOCS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 10, 2025 15:39 ET (20:39 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4167","BK4613","DOCS","BK4539","BK4551"],"gpt_icon":0},{"id":"2582878469","title":"OpenAI considers consumer health tools in push beyond core AI offerings, Business Insider reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2582878469","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582878469?lang=en_us&edition=fundamental","pubTime":"2025-11-10 19:52","pubTimestamp":1762775551,"startTime":"0","endTime":"0","summary":"Nov 10  - OpenAI is weighing building consumer health products, including a generative AI-powered personal health assistant, as the ChatGPT maker aims to move beyond its core offerings, Business Insider reported on Monday, citing sources close to the company.OpenAI did not immediately respond to a Reuters request for comment.Tech giants such as Google, Amazon and Microsoft have long tried to give consumers control over their medical data, often with limited success.Google GOOGL.O shut its health record service in 2011 due to low traction, while Amazon AMZN.O wound down its Halo fitness tracker business in 2023. Microsoft's MSFT.O HealthVault platform also failed to attract widespread adoption.OpenAI's healthcare push follows strategic hires, including Nate Gross, cofounder of physician network Doximity DOCS.N, as head of healthcare strategy in June, and former Instagram executive Ashley Alexander as vice president of health products in August.At the HLTH conference in October, Gross sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4N3WM0SR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989764748.USD","LU0158827781.USD","LU0345770993.USD","LU2750360997.AUD","LU2360108059.USD","LU0095938881.EUR","LU0162691827.USD","LU1340139317.AUD","SG9999014559.SGD","LU0106261372.USD","LU0079474960.USD","LU2471134796.USD","LU0312595415.SGD","IE0009G5SDU7.USD","IE000ITXATA3.USD","LU1551013342.USD","LU0472753341.HKD","LU2237957902.USD","LU2471134879.HKD","LU2360106780.USD","LU1989772923.USD","LU1989764664.SGD","LU2083900584.USD","LU2462157665.USD","VNO","LU0057025933.USD","LU1496350171.SGD","LU1935042488.USD","BK4507","LU0661504455.SGD","LU0070217475.USD","ALX","LU0323239441.USD","DOCS","USAW.SI","LU1989772840.SGD","LU2750360641.GBP","LU0889566641.SGD","LU1181866309.USD","LU2237957811.SGD","LU1066051498.USD","LU0708995401.HKD","LU1839511570.USD","LU2471134523.USD","LU0061475181.USD","IE000YTNTUN2.SGD","LU0689626769.HKD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.doximity.com","stockEarnings":[{"period":"1week","weight":-0.1399},{"period":"1month","weight":-0.1629},{"period":"3month","weight":-0.3787},{"period":"6month","weight":-0.2108},{"period":"1year","weight":-0.1601},{"period":"ytd","weight":-0.1734}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.1345},{"period":"ytd","weight":0.1759}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.007016},{"month":2,"riseRate":0.75,"avgChangeRate":0.135043},{"month":3,"riseRate":0,"avgChangeRate":-0.102936},{"month":4,"riseRate":0.25,"avgChangeRate":-0.054203},{"month":5,"riseRate":0.25,"avgChangeRate":-0.057607},{"month":6,"riseRate":0.75,"avgChangeRate":0.07265},{"month":7,"riseRate":0.8,"avgChangeRate":0.057616},{"month":8,"riseRate":0.6,"avgChangeRate":0.081551},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012183},{"month":10,"riseRate":0,"avgChangeRate":-0.088019},{"month":11,"riseRate":0.6,"avgChangeRate":0.088989},{"month":12,"riseRate":0.4,"avgChangeRate":-0.040072}],"exchange":"NYSE","name":"Doximity, Inc.","nameEN":"Doximity, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Doximity, Inc.(DOCS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Doximity, Inc.(DOCS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Doximity, Inc.,DOCS,Doximity, Inc.股票,Doximity, Inc.股票老虎,Doximity, Inc.股票老虎国际,Doximity, Inc.行情,Doximity, Inc.股票行情,Doximity, Inc.股价,Doximity, Inc.股市,Doximity, Inc.股票价格,Doximity, Inc.股票交易,Doximity, Inc.股票购买,Doximity, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Doximity, Inc.(DOCS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Doximity, Inc.(DOCS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}